Stock Analiz

Angiodynamics Inc. (ANGO) stock forecast and price target

Price $11.87 · data as of November 13, 2026

12-month price target

Average target$19.75
Upside / downside+66.4%
Analysts4
ConsensusNone
Low $17.00Average $19.75High $24.00

Gold marker: average target · white marker: today’s price ($11.87)

Analyst ratings

Strong buy 0Buy 4Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends May 31, 2027
$-0.28−86.7%$338M
Next fiscal year
ends May 31, 2028
$-0.11+59.5%$355M
Next quarter
ends November 30, 2026
$-0.07+0.0%$84M
Quarter after
ends February 28, 2027
$-0.09−550.0%$83M

Consensus of the analysts covering Angiodynamics, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.

Our model vs. Wall Street

Analysts see 66.4% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Angiodynamics’s intrinsic value about 77% below today’s market value, and it scores 1.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Angiodynamics stock price target?

The average 12-month target from 4 analysts is $19.75, 66.4% above the current price of $11.87 Targets range from $17.00 to $24.00.

Is Angiodynamics a buy according to analysts?

The consensus rating is “None” (4 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Angiodynamics expected to earn?

Analysts expect EPS of $-0.28 for the fiscal year ending May 31, 2027 and $-0.11 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.